FGAM
EBS icon

Financial Gravity Asset Management’s Emergent Biosolutions EBS Stock Holding History

Financial Gravity Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-110
Closed -$275 – 1720
2024
Q1 		$275 Buy
110
+78
+244% +$176 ﹤0.01% 1553
2023
Q4 		$72 Buy
32
+16
+100% +$38 ﹤0.01% 1292
2023
Q3 		$33 Buy
16
+9
+129% +$50 ﹤0.01% 1080
2023
Q2 		$107 Sell
7
-3
-30% -$28 ﹤0.01% 1290
2023
Q1 		$171 Sell
10
-2
-17% -$24 0.01% 646
2022
Q4 		$198 Sell
12
-240
-95% -$3.71K ﹤0.01% 946
2022
Q3 		$346 Sell
252
-120
-32% -$3.34K 0.01% 449
2022
Q2 		$513 Sell
372
-120
-24% -$4.1K 0.02% 388
2022
Q1 		$679 Sell
492
-67
-12% -$2.96K 0.02% 371
2021
Q4 		$725 Buy
559
+542
+3,188% +$24.5K 0.02% 429
2021
Q3 		$50K Hold
17
– – 0.02% 569
2021
Q2 		$63K Sell
17
-35
-67% -$2.25K 0.02% 489
2021
Q1 		$4.85K Sell
52
-54
-51% -$5.53K 0.1% 148
2020
Q4 		$9K Buy
+106
New +$9.73K 0.01% 186
2020
Q2 		– Sell
-1,068
Closed -$61.7K – 241
2020
Q1 		$61.7K Sell
1,068
-447
-30% -$25.8K 0.19% 61
2019
Q4 		$54K Sell
1,515
-746
-33% -$40.5K 0.04% 600
2019
Q3 		$118K Sell
2,261
-504
-18% -$23.5K 0.1% 182
2019
Q2 		$134K Sell
2,765
-593
-18% -$28.4K 0.11% 194
2019
Q1 		$169K Buy
+3,358
New +$198K 0.14% 153
2018
Q3 		$192K Sell
3,246
-148
-4% -$8.64K 0.2% 127
2018
Q2 		$187K Sell
3,394
-325
-9% -$16.9K 0.18% 137
2018
Q1 		$190K Buy
+3,719
New +$185K 0.19% 104

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Financial Gravity Asset Management's EBS Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of Emergent Biosolutions (EBS) in Q2 2024, closing a stake of 110 shares — an estimated $275 sold.

Financial Gravity Asset Management first reported a position in EBS in Q1 2018 and held it in 22 quarters. The position peaked at $192K in Q3 2018. 141 funds tracked by Wall St. Rank hold EBS as of Q2 2024.

  • Financial Gravity Asset Management reported no remaining Emergent Biosolutions position as of Q2 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 110 Emergent Biosolutions shares in Q2 2024, an estimated $275.
  • Financial Gravity Asset Management first reported a position in Emergent Biosolutions in Q1 2018 and held it in 22 quarters.
  • Financial Gravity Asset Management's Emergent Biosolutions position peaked at $192K in Q3 2018.
  • 141 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.